$500 in Hexo (TSX:HEXO) Stock at the Start of 2020 Is Worth This Much Now!

If you’d invested $500 in Hexo Corp. (TSX:HEXO)(NYSE:HEXO) stock at the start of this year, it would be worth under $250 today. 

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Hexo (TSX:HEXO)(NYSE:HEXO) stock dropped 11% yesterday. In fact, the stock has been steadily declining for much of this year. If you’d invested $500 in Hexo stock at the start of 2020, it would be worth just under $250 today! Half of the company’s market value has evaporated in just six months. 

However, investors should consider what the stock could hold for the future. In other words, what would $500 invested in Hexo stock today be worth by 2021? Here’s a closer look. 

Future potential

The size and promise of the legal cannabis sector hasn’t changed much over the past few years. This is still an exciting new sector of the economy that could be worth hundreds of billions of dollars by the end of the decade. One estimate suggests the medical and recreational cannabis sector would generate US$73.6 billion (CA$100 billion) by 2027.

That means there’s plenty of room for expansion. Hexo stock is already a leader in the sector. However, now its market value is far more realistic and attractive. Long-term investors who appreciate the growth potential should dig deeper into Hexo’s fundamentals.

Hexo stock’s valuation

The pendulum of investor sentiment seems to have swung from exuberance to pessimism. In early 2019, Hexo stock was worth $10.5. Now, it’s a fraction of that price. Structural issues in the marijuana sector and a looming debt problem has compressed the valuation of all cannabis stocks. 

That means investors are overlooking Hexo stock’s underlying strengths. The company’s financials seem to be improving. In its most recent quarter, the company declared top-line figures that were higher than estimates. It’s on track to generate $80-$100 million in revenue this year. 

Meanwhile, Hexo’s market value is currently $433 million. That implies a price-to-sales ratio of four. Assuming Hexo can achieve a 12.5% profit margin in the future, the forward price-to-earnings for Hexo stock could be just 35. That’s not bad for a company that’s expanding sales at a 30% sequential rate. 

When you consider the size of the market, the company’s established partnerships, and its track record of tangible growth, Hexo stock seems fairly valued. However, investors must be aware of the risks involved in any cannabis stock. The supply, over-production, and debt issues could take a few years to resolve. Value will be unlocked gradually. 

Bottom line

The legal cannabis sector has had a rough few years. Structural issues and a massive debt burden have deflated investors’ excitement for this industry. Hexo stock has been a prime victim of this shift in sentiment. 

If you’d invested $500 in the stock at the start of this year, it would be worth under $250 today. Investors have lost hundreds of millions of dollars over the past six months. The destruction in wealth has been even deeper over the past year. Hexo stock is now worth just 10% of its early 2019 price. 

However, considering the steady expansion of HEXO’s top line and its current valuation, the stock seems attractively priced. Investors seeking growth at a reasonable price should certainly add Hexo stock to their watch list. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »